Single-Dose, Open-Label Study of the Differences in Pharmacokinetics of Colchicine in Subjects with Renal Impairment, Including End-Stage Renal Disease

Are Dosing Adjustments Required for Colchicine in the Elderly Compared with Younger Patients?

(2012) Suman Wason et al.   ADVANCES IN THERAPY

Reduced Glomerular Function and Prevalence of Gout: NHANES 2009–10

(2012) Eswar Krishnan   PLoS One

Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P-glycoprotein inhibitors

(2011) Robert A. Terkeltaub et al.   ARTHRITIS AND RHEUMATISM

Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008

(2011) Yanyan Zhu et al.   ARTHRITIS AND RHEUMATISM

High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study

(2010) Robert A. Terkeltaub et al.   ARTHRITIS AND RHEUMATISM

Managing gout: How is it different in patients with chronic kidney disease?

(2010) H. EL-ZAWAWY et al.   CLEVELAND CLINIC JOURNAL OF MEDICINE

Consensus Guidelines for Oral Dosing of Primarily Renally Cleared Medications in Older Adults

(2008) Joseph T. Hanlon et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Association of Incident Gout and Mortality in Dialysis Patients

(2008) S. D. Cohen et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Hepatobiliary excretion and enterohepatic circulation of colchicine in rats

(2007) Yu-Jen Chen et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS